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Abstract
Stochastic methods for modelling disease dynamics enables the direct computation of the probability of elim-
ination of transmission (EOT). For the low-prevalence disease of human African trypanosomiasis (gHAT),
we develop a new mechanistic model for gHAT infection that determines the full probability distribution
of the gHAT infection using Kolmogorov forward equations. The methodology allows the analytical inves-
tigation of the probabilities of gHAT elimination in the spatially-connected villages of different prevalence
health zones of the Democratic Republic of Congo, and captures the uncertainty using exact methods. Our
method provides a more realistic approach to scaling the probability of elimination of infection between
single villages and much larger regions, and provides results comparable to established models without the
requirement of detailed infection structure. The novel flexibility allows the interventions in the model to
be implemented specific to each village, and this introduces the framework to consider the possible future
strategies of test-and-treat or direct treatment of individuals living in villages where cases have been found,
using a new drug.
Keywords: Mathematical Model, Kolmogorov Forward Equations, African Trypanosomiasis, African Sleep-
ing Sickness
Background
In mathematical epidemiology, a growing number of models employ the use of stochastic events to describe
infection dynamics. These stochastic methodologies, such as the Gillespie or tau-leaping algorithm, typically
use a large number of event-driven stochastic simulations to estimate a distribution of possible behaviours for
an epidemic [1]. A central benefit of stochastic models is that the random nature of each realisation means
a larger range of outcomes is captured than simply the equilibrium dynamics predicted by a deterministic
model [2]. These stochastic methods are also integer-based and so the exact number of people infected at
a given time is monitored, including when infections reach zero; a deterministic model will never reach zero
infections and so a threshold needs to be applied to reach the elimination [3–5]. Thus, a model in a stochastic
framework, will have different expected behaviour and be better suited than a deterministic variant when
close the the elimination threshold, either due to low infection numbers or small populations [6].
However, event-driven stochastic methods require a large number of realisations of the epidemic process
to be generated to be confident that the full distribution of events has been captured; even then this is
still only an approximation of the true probability distribution of the potential trajectories for the infection
dynamics in time. This is particularly important if there are any rare events of the system — something
that requires more realisations to determine the true frequency at which they occur [6]. Alternative to these
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event-driven stochastic simulations, the Kolmogorov forward equations provide a method incorporating the
stochastic behaviour in a set of ordinary differential equations (ODEs), which fully determine the probability
distribution of the epidemic over all possible infection states for the population [6]. This approach is simple
to formulate, as many systems are linear in terms of the probability of being in each infection state, and so
can be written in a matrix formulation; other methods exist for when this is not the case [7]. The system is
thus easy to solve using standard methods and provides a complete description of the dynamics. It is also
much faster to solve than repeatedly generating realisations of the stochastic process. The solutions are also
numerically exact and an array of derived quantities can be directly calculated.
Kolmogorov forward equations have been utilised in several epidemiological contexts [8–10] and discussed
as a powerful tool, but are not widely used due to constraints on computer memory [11]. Every possible
infection state must be explicitly tracked and so if a population is large (and particularly if each individual
can be in any of a large number of infection states), the number of these states quickly becomes prohibitive
to the method, as the number of required computations becomes infeasible. Simulation methods take a
lot of computation time; Kolmogorov forward equation methods take a lot of memory storage capacity
[12]. Therefore, a Kolmogorov forward equation approach to modelling infections dynamics would be most
applicable for a disease with a relatively small number of cases that has the potential to achieve elimination
[13]. One such disease is gambiense human African trypanosomiasis (gHAT).
Infection with gHAT is caused by the parasite Trypanosoma brucei gambiense and is transmitted by
tsetse across Central and West Africa, with the majority of infection occurring in the Democratic Republic
of Congo (DRC). This infection has been traditionally controlled with active and passive screening, with
subsequent treatment of infected individuals, and has been targeted for elimination of transmission (EOT) by
2030 by the World Health Organization (WHO). There have been a substantial number of recent modelling
studies that use compartmental models for gHAT, with these studies typically using deterministic systems of
ordinary differential equations (ODEs) [14–18], with more recent studies also considering stochastic event-
driven approaches [19–22].
Here, we have developed new model for gHAT infection in spatial connectivity of villages within health
zones of DRC. We use a lower-dimensional state space for infection than considered in the majority of the
literature, which hence allows for Kolmogorov forward equations to be used to define the dynamics. This
formulation fully captures the possible behaviour of the infection in a stochastic framework, while exhibiting
the advantages of providing the full and exact distribution of the infection states. We investigate the
probabilities of gHAT persistence or extinction and compute expected times until elimination of infection,
which, despite the lower-dimensional infection structure, provides comparable results to more commonly
used methods.
Furthermore, the Kolmogorov forward equation model provides the necessary formulation to explore
the interactions between a large number of villages. Village-specific simulations can mimic the real-world
interventions observed at the level at which they occur, with the results then realistically scaled up to larger
regions, where elimination of infection can be considered at more meaningful geographic scales [23]. In the
context of gHAT, the method provides a link between individual village [19] and health zone [18] modelling,
while including the stochastic properties required to directly simulate elimination of infection, we can assess
potential strategies and progress towards achieving elimination goals.
Methods
Kolmogorov forward equations
We construct our Kolmogorov forward equation model by adapting the structure of the suite of gHAT models
first presented in Rock et al. [14] and updated in Crump et al. [17]. Unlike these previous models, the model
presented in this manuscript contains just two infection states for a person (susceptible and infected) and
two types of people (low- and high-risk of exposure to tsetse bites), and does not explicitly model the number
of infected tsetse, the biological vector of the disease.
We derive the new model equations by replacing the tsetse dynamics of previous models with the quasi-
equilibrium solution, in order to limit the number of model compartments. For the case gHAT, this assump-
tion is justified by the short life-expectancy of the vector (tsetse) [24] and the long timescales of the infection
in humans [25]. The number of infection compartments for humans are also reduced from five (susceptible,
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Figure 1: Model diagrams for the two gHAT models. The left panel shows the full higher-dimensional ODE
model from Crump et al. [17] that includes tsetse dynamics. The right panel shows the lower-dimensional
spatially-connected Kolmogorov forward equation model presented in this manuscript. In the right panel
the larger box represents an example village with the smaller boxes being the other villages (which have
identical structure). In both panels the solid black lines shows the rate of movement between compartments
and dashed black lines shows the the result of active screening and treatment of infected individuals. The
dashed grey paths show interaction between humans and tsetse or between all villages, respectively in each
panel.
exposed, infected Stage 1, infected Stage 2, and hospitalised) to two, whereby exposed, infected Stage 1 and
infected Stage 2 are now included as a single infected state, I, and the former susceptible and hospitalised
compartments are now given as all susceptible S (Figure 1). The total human population size is constant
and denoted as N , with a small natural mortality rate of people, µ, replaced by new susceptible individuals.
We retain a risk structure whereby a small minority of the population is high-risk, with a higher exposure
to biting tsetse and failure to attend active screening.
This leaves four possible infection states for any person, and therefore this lower-dimensional model
structure (shown in an ODE framework) is given by Equations 1 and 2.
dSi
dt
= (µ+ ψ(Y )) Ii − ζi(I1, I2)Si, (1)
dIi
dt
= ζi(I1, I2)Si − (µ+ ψ(Y )) Ii, (2)
for i = 1, 2, for the low- and high-risk group respectively. The natural human mortality rate, µ, determines
the total human birth rate, µN , such that a constant population size is maintained. The recovery rate, ψ(Y ),
is dependent on time due to increased detection rates in at later times and is derived from a combination of
parameters from Crump et al. [17], detailed in the supplementary material. The force of infection is given
by ζi(I1, I2), which is a function of the risk class and the number of people infected in each risk class, further
depending on the quasi-equilibrium solution for the tsetse (Figure 1). See supplementary information a full
explanation of the derivation for these model parameters.
To translate this re-formulated model (Equations 1 and 2) into the Kolmogorov forward equations, we
first consider infection state of the population. Since we assume constant population sizes N1 and N2 in each
risk group and Si + Ii = Ni for i = 1, 2, the infection state is fully determined by the number of infected
low- and high-risk people I1 and I2. Thus, we define the probability of being in a given state at time t as
PI1,I2(t). From this population infection state, there are four possible transitions to different states: a low-
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risk human can recover or die, a high-risk human can recover or die, a low-risk human can get infected, or a
high-risk human can get infected (since we assume a constant population size, death is followed by immediate
replacement in the susceptible class and so we do not consider this separately to recovery). Therefore, the
Kolmogorov forward equations are given by:
dPI1,I2(t)
dt
= −PI1,I2(t)(ζ1 (I1, I2, t) (N1 − I1) + ζ2 (I1, I2, t) (N2 − I2)
+ (µ+ ψ(Y )) (I1 + I2))
+ PI1−1,I2(t)ζ1(I1 − 1, I2, t) (N1 − I1 + 1)
+ PI1,I2−1(t)ζ2(I1, I2 − 1, t) (N2 − I2 + 1)
+ PI1+1,I2(t) (µ+ ψ(Y )) (I1 + 1)
+ PI1,I2+1(t) (µ+ ψ(Y )) (I2 + 1) , (3)
where I1 = 0, ...,M1, I2 = 0, ...,M2, and PI1,I2(t) = 0 for I1 < 0 and I2 < 0. The values M1 and M2 are the
maximum number of people possible to be infected in each risk group.
In theory, theM1 = N1 andM2 = N2, however because in practice gHAT is a low-prevalence infection [26],
we can reduce the state space of the model and impose a lower maximum threshold, while retaining high
model accuracy. We ensure that the probability of exceeding the threshold is very small (less than 1×10−8),
with the values of Mi dependent on Ni, and explicitly given in the supplementary material.
Thus, the Kolmogorov forward equations (Equation 3) comprise of a system of (M1 + 1)(M2 + 1) ODEs
(since the low-risk infected population can take any value between 0 and N1 and similarly for the high-risk).
The Kolmogorov forward equations are a linear system, and hence we simplify the notation by writing the
equations in matrix form. By defining the probability vector:
p(t) = (P0,0(t), P1,0(t), ..., PN1,0(t), P0,1(t), ..., PN1,N2(t)), (4)




where Q(t) is the rate matrix of all transition rates at time t. We subsequently give the time t in both the
year Y and number of days into that year d and hence, p(t) = p(Y, y). However, we note that Q(t) = Q(Y )
because we assume, as per Crump et al. [17], that the change in the rate matrix is due to an increase in the
rate of passive detection of infection due to improvements in the passive surveillance system, which occurs
annually.
Since the equations of Crump et al. [17] consider large populations of roughly 100,000 people, rather
than much smaller villages, we additionally include a rate of importation of infection into a village, due to
movement of people between villages, for which we use a value derived in Davis et al. [19] and denote by
δ(Y ). The event of an external importation increases the number of infected people in either risk group by
one and adds terms to Equation 3 representing a change of state from I1 low-risk infected and I2 high-risk
by increasing from I1− 1 to I1, increasing from I2− 1 to I2, and increasing from I1 and I2 to I1 + 1 or I2 + 1
respectively:
+ PI1−1,I2(t)δ(Y ) (N1 − I1 + 1)
+ PI1,I2−1(t)δ(Y ) (N2 − I2 + 1)
− PI1,I2(t)δ(Y ) ((N1 − I1) + (N2 − I2)) . (6)
In matrix notation, we include these new terms in matrix QE(Y ), whereby the rate matrix is given by
Q(Y ) = (QV (Y ) + QE(Y )), for the village and external terms respectively.
Additionally, active screening, the process whereby a large number people in a village are targeted to be
screened for the disease and then treated if infected, is modelled as a the multiplication of the probability
vector p(Y,y) by a lower-triangular transition matrix A(Y ). In line with previous modelling studies, we
assume that only the low-risk class are affected by this discrete-time event that occurs annually at the
beginning of each year, whereas the high-risk class do not attend active screening events. The active screening
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matrix A(Y ) is calculated, for a given screening coverage (which can change each year), by the use of a
hypergeometric distribution to determine the number of infected people screened, followed by a binomial
distribution to find the number of infections detected due to the imperfect sensitivity of the test (full details
are in the supplementary material).
We assume that active screening began in 1998 [27], and the system was previously at endemic equilibrium
given there had been no screening for several years previously. Therefore, we derive the full distribution of
infection states for a population in day d of year Y as




A (i) exp (−365 (QV (i) + QE (i)))
)
A (Y ) exp (− (QV (Y ) + QE(Y )) y) ,
(7)
for Y ≥ 1998 and 0 ≤ d ≤ 365. Active screening in year Y is modelled as occurring at the start of the year
(d = 0), and hence the probability state just before active screening in year Y is given by p (Y − 1, 365). We
calculate p (1997, 365) by finding quasi-stationary equilibrium, finding the eigenvector corresponding to the
largest eigenvalue of the rate matrix, (QV (1997) + QE (1997)).
Parameter values
The parameters are taken from Crump et al. [17] and transformed into the new parameters of the Kolmogorov
forward equations (see supplementary material). The values of the original parameters are either fixed where
well-defined in the literature, and specific to DRC, or are parameters reflective of a high-incidence health
zone (by using the median estimate of the posterior from fitting to screening and incidence data from the
health zone Kwamouth in Mai Ndombe province using a Metropolis–Hastings MCMC algorithm [17]). The
data which span 2000–2016 came from the WHO HAT Atlas [26].
In the present study we do not account for vector control, as our primary focus here is to understand the
village-level screening dynamics. Furthermore, only one health zones of DRC had large-scale vector control
in situ prior to 2018 [28] (the study period with available data).
We additionally present similar results for the low-incidence exemplar health zone (based on parameter-
isation from Mosango health zone of Kwilu province) for comparison in Figure 5 and in the supplementary
material. We note that the methodology presented here could alternatively be applied to any other health
zone or region.
Results
Infection dynamics of a single village
Solving the Kolmogorov forward equations, using the matrix exponential in the form presented in Equation
7, we can obtain projections of how the infection dynamics will change in time in full probabilistic form. As
an illustrative example, we calculate the distribution of infection up to the year 2030 for a village of 1,000
people in a high-incidence health zone, assuming that within the village there is an active screening coverage
of 50% every year (Figure 2a). We are assuming a small rate of infectious importations from movement of
people that decreases with time, δ(Y ) = (3.4 × 10−6) exp(−0.1071(Y − 2000)) days−1, and that the village
starts at endemic equilibrium conditions in 1998, calculated as the steady state of the Kolmogorov forward
equations.
The results show that the introduction of active screening drives down the expected number of infected
people from the steady-state distribution in 1998. By 2030, there is a probability of 0.90 that there are
no infected people in this example village. The steady-state is concentrated on negligible infection levels
assuming the active screening is maintained. The full probability distribution does, however, show that for
this individual village there is still some probability the infections will not fall as quickly, or indeed remain
constant or increase.
These results are dependent on the import rate between villages. Without the importation rate, there is
an absorbing disease-free population state dynamics, which the population would eventually move towards
(a steady-state of no infection). This is because without the importation rate, if infection levels reach zero
there is no person to re-introduce infection the population (albeit through tsetse in practice).
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Figure 2: Illustrative example of the distribution of infection in a single example village of population size
N = 1, 000 for two scenarios. (a) A gHAT-endemic village with 50% annual active screening coverage and a
small rate of infectious importations. (b) A village with local elimination of infection pre-2000 followed by
the introduction of one high-risk infected person in 2000, including a small rate of infectious importations
in the future, but no active screening. For each scenario, the top panel shows the distribution of the total
number of infected people in time and the lower panels show the distribution between the risk groups at
selected time points. The red line in the top panel shows the mean expected dynamics and the red crosses
in the bottom panels shows the expected numbers in each risk class at that time.
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Conversely to an endemic village, we consider a hypothetical village in a high-incidence health zone that
was infection-free in 1998 and therefore not targeted for active screening (Figure 2b). We predict some level
of resurgence on average in the village if a single high-risk person of the village became infected through
travelling to another village. There is a high probability of onward transmission in the village; the expected
number of infected people increases initially, before decreasing again. However, infection is unlikely to be
maintained in the long term, even without additional controls — there is a probability of 0.83 of a return to
no infection by 2030.
Infection dynamics across multiple villages
The infection dynamics in individual villages informs us about the probability of local elimination of infection
for an average village, but at a larger scale, such as health zone or country level, elimination of infection will
depend on more than the probability of elimination in individual villages. While the distribution of gHAT
infection is heterogeneous across the DRC [29], highly-clustered incidence means that local movement of
people will affect the probability of elimination in neighbouring villages. The rate of infectious importations
in a village will be dependent on the total infection level in the area.
Therefore, to consider the dynamics across multiple villages in a region, we modify our rate of infectious
importations to remove the exponential decrease in time matched to the trend in global infections and
replace this with a term proportional to the total number of expected infections in model predictions across
all villages of the local study region such that δ(1998) = (3.4 × 10−6) days−1. The supplementary material
provides a complete description of how the rate of infectious importations is formulated.
We consider the expected number of infections and the probability of elimination of infection for four
groups of 10,000 people, comprised of groups of villages of different sizes (N = 10, 000, 1, 000, 100 and 10)
(Figure 3) to understand the impact of the metapopulation structure [23]. The smaller village population
sizes within total populated area have fewer expected gHAT infections and a higher probability of elimination
of infection. The reduced number of interactions of mixing in smaller villages also results in a lower steady-
state from before the active screening begins. There is a much lower probability of elimination of infection
when there are fewer larger villages. For 1,000 villages with population size N = 10, the probability of
elimination of infection in 2030 is > 0.99, while for just one village of size N = 10, 000, there is a smaller
probability for elimination of infection by 2030 at 0.77. This is in agreement with results of metapopulation
studies, where more stochastic fade-outs of infection occur in the smaller populations, leading to a greater
probability of elimination of infection across larger areas when sub-divided into more populations [30]. The
example here highlights the benefit of modelling the full stochastic dynamics, where the small population
sizes determine the frequency of extinction events; the results from an ODE model with constant population
size would not vary with the size of the population.
Infection dynamics across a health zone
While we have considered theoretical villages to explore the behaviour of the Kolmogorov forward equation
model, we now use data from the WHO HAT Atlas [31] to obtain a list of real villages size distributions
to apply our model to. Since our model for a high-incidence health zone uses parameters matched to the
data from the health zone of Kwamouth, we extract the population sizes of each village in Kwamouth (see
supplementary material for details) along with the past active screening coverage. A plausible screening
pattern is obtained taking the mean active screening coverage across all screenings and the probability that
any particular village listed in the WHO HAT Atlas is screened in a given year. For Kwamouth, these values
are a 68.6% coverage occurring at a probability of 0.23 each year using active screening data from 2000–2018
(see supplementary material for details). This active screening scheme is incorporated into the model by a
new parameter for the probability of an active screening event in a village. Thus, we model active screening
as the linear combination of the probability of no active screening multiplied by the current distribution and
the probability of active screening multiplied by the distribution after an active screening event. We note
that this is not expected to reproduce the transmission and reporting trends of the past 19 years robustly
– as we do not use screening patterns specific to individual villages, nor allow for coverages higher or lower
than the mean – however this does allow us to investigate general behaviour of the infection system using
plausible real-world-like screening patterns.
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Figure 3: Infection dynamics in a total population of 10,000, partitioned into groups of villages of different
sizes N = 10, 000, 1, 000, 100 and 10. The annual active screening coverage is 50% and projections are
started for the equilibrium distribution in 1998. (a) The expected number of infections. The shaded region
shows the 95% prediction intervals around the solid line for the expected value. (b) The probability of local
elimination of infection.
We additionally adapt the value of the rate of importations of infection at steady state (previously taken
from Davis et al. [19]). We calculate the value that is now specific to the health zone of Kwamouth as
δ(Y ) = 2.86 × 10−6 days−1, which is determined by matching the steady state of the whole health zone to
the steady state of the system of ODEs in the original model for Kwamouth.
Applying the full Kolmogorov forward equation model to the high-incidence health zone, we obtain a
full probability distribution in time for each village. We present the probability distribution of infection
across the risk groups for a selection of villages of different sizes (N = 100, 971, 5, 628 and 20, 697) at key
time points 4) and for the whole health zone across all simulated time (Figure 5). Similar results for the
lower-incidence health zone are presented in the supplementary material.
The expected number of infections in all villages decreases in time, such that by 2030 most of the
probability is centred around no infection. For the smallest villages, there is a large probability of local
gHAT elimination by 2030 (> 0.99 for the village of size N < 100) as there are initially few or no cases,
which are then identified by active screening, or passive screening and treatment or death. However, for the
largest villages, such as the one with a population of N = 20, 697, there is a high probability of continued
infection with a probability of just 0.26 that elimination of infection will be met in that village by 2030.
Hence, we will frequently see local elimination events, with global persistence across the health zone [30].
Additionally, we note that our results are not unique to this approach and the dependence on population
size for the probability of elimination can be approximated in an ODE framework by imposing different
thresholds for elimination [21].
Active screening is shown to reduce the infection. This is visually explicit in the column for 2000, where
there are separate high probability clouds for whether an active screening has occurred and hence the number
of infected people in the low-risk group identified and treated (Figure 4). At the beginning of 2000, active
screenings may have occurred in both 1998 and 1999 and so in the bottom left panel of Figure 4 (village of
population size N = 20, 697), is is clear that there are four possible outcomes highlighted as separate regions
of the probability distribution: an active screening event occurred in both 1998 and 1999, just 1998, just
1999, or neither 1998 or 1999. This behaviour is less obvious in some smaller villages as the high probability
regions overlap, yet is still present. We note that since active screening is identifying only low-risk individuals,
infection is being pushed down but proportionally most of the reduction is in the low-risk group.
The decline in expected infection in all of individual villages is also evident total infection of the health
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Figure 4: The risk distribution of infection in selected villages of an exemplar high-incidence health zone at
different time points (the years 2000, 2010, 2020 and 2030); the first possible active screening of each village
was in 1998. There are 418 villages with populations ranging between 3 and 20,697 of which we present
the probability distribution of infected people in four villages (N = 100, 971, 5, 628 and 20, 697). On each
subplot the x-axis represents the number of high-risk people infected, and the y-axis, the number of low-risk
people infected. The risk distribution of infection for the alternative, low-incidence health zone are presented
in the supplementary material.
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Figure 5: The total infection in the exemplar high-incidence and low-incidence health zones. We assumed
the high-incidence health zone had a population of 206,135 people made up 481 distinct villages, while the
low-incidence had a population size of 107,685 of 204 villages. (a) The expected number of infections across
all villages in time. The shaded region shows the 95% prediction intervals. (b) The probability of zero
infections in time and hence elimination for all villages in each health zone together.
zone (Figure 5). This is calculated as the sum of the expected infection in each village. Note that here we do
not present the number of cases, but the underlying infections — case numbers would be substantially lower
as there are typically high levels of under-reporting [32]. Whilst our focus here is elimination, we additionally
show how these levels of underlying infections correspond to annual active and passive case reporting for
both high- and low-incidence exemplar health zones in the supplemental material.
By 2030, the expected number of infected people have greatly decreased, yet persist in low numbers.
This is mirrored in the probability of elimination of infection, calculated as the product of achieving zero
infections in all villages of the health zone, which is less than 10−4 by 2030 in our high-incidence health
zone if this active screening coverage remains constant and only identifies low-risk infected individuals, with
the mean expected year of elimination after 2040. Using parameter values in the model matched to WHO
HAT Atlas data for the low-incidence health zone, we observe an earlier mean expected year of elimination
of infection in 2029.
Discussion
The Kolmogorov forward equation model facilitates a powerful and efficient way to analyse the dynamics of
a low-prevalence infections such as gHAT. This method presented here, utilising a lower-dimensional model
structure than commonly used models, is fast to compute (with sufficiently small populations) and yet
maintains a good correspondence with more complex approaches. The nature of the implementation means
that various interesting properties can easily be explored, with exact methods for calculating extinction times
and expected dynamics [6]. This approach has also allowed the model to be easily extended to consider the
interaction of multiple villages and even to consider the dynamics of persistence at the health zone level by
linking the total number of infected individuals to the rate of infectious imports into the villages.
Using this model, we conclude that based upon the strategy of active screening at the mean level, the
expected year of elimination of infection may be beyond 2040 for high-incidence health zones like Kwamouth
and around the target year of 2030 in low-incidence health zones like Mosango. As outlined in the methods,
there are a few reasons why the exact results presented here may not completely align with the infection
dynamics of specific health zones; this includes using mean screening coverage in villages, rather than village-
and year-specific coverage, and the Kolmogorov forward equation model parameters have not been directly
10
fitted to data, which would be needed to ensure a robust correspondance between observed outputs and
reporting trends.
Improving the match to specific health zones is beyond the scope of the present study, however we do
see that our general messages are in line with deterministic predictions using this parameterisation but at a
health zone level; Huang et al. [18] predicted that the year of elimination of infection would be after 2040
for Kwamouth and in 2031 for Mosango, using a similar model and the mean coverage of active screening.
Likewise, stochastic models at a health zone level, found that without COVID-19 interruptions to gHAT
activities, elimination might be expected in 2025 in Mosango (with this slightly earlier prediction may be
explained by higher assumed screening from 2017 onwards) [21]. This general agreement between either
connected village scale and health zone scale models is reassuring (detailed further in the supplement) and
supports continued use of both model frameworks if acknowledging the stochastic and parameter uncertainty;
however, by formulating connected village-scale methods it is possible to consider spatial dynamics in a more
nuanced way.
We note that in considering the populations, we have only used villages that are listed in the WHO
HAT Atlas and there are known to be additional villages within these health zones that are not listed, since
they may not have ever been screened. Hence, the distribution of active screening is not truly as uniformly
distributed across the health zones as presented here. As shown in the supplementary material, we also know
that screening coverage and frequency is correlated with population size of a settlement, and so adapting
our model to account for this would also likely result in more accurate predictions. The proportion of people
in each risk class is also constant for all population sizes in the model, whereas we could speculate that
the larger populations are more town-like and perhaps have fewer high-risk members. This potential over-
estimation of high-risk people in the large populations could explain some of the very high gHAT persistence
probabilities seen in results for these populations (Figure 4).
The assumption that movement of infected individuals is proportional to the expected number of people
infected in the health zone, rather than the full distribution, is also a simplification to avoid calculating all
possible combinations infection states in each village. This simplification would be expected reduce the size
of the prediction intervals for small groups of villages, tending towards the mean behaviour; there would
otherwise be a small probability of many villages having a much lower or higher number of infected people,
which would decrease or increase the importation rate respectively. However, at the health zone level, with a
large number of villages, the mean behaviour is a good approximation and so this simplification has minimal
impact on the results.
In addition, we consider a probability of active screening every year, despite the fact that continued active
screening is unlikely to be necessary for small villages, where the infection is almost certain to be locally
eliminated in latter years. To improve the plausibility of the model, we could add a cessation criterion,
similar other studies [20, 33, 34]. This is less straightforward to implement in this probabilistic framework
than in the tau-leaping scheme, as we do not consider specific realisations of the model where the infection is
either detected or not, but have a full probability distribution of all possible infection states. One potential
solution could be to link the probability of being screened to the probability of observing a case in active
screening. We do show that the assumption of a single screening event each year, as opposed to continuously
throughout the year, shows negligible differences and so adopt this method for simplicity (see supplementary
material).
We have no data on the movement of people between villages, and so the rate of importation was
estimated by matching to the probability of detecting infection on the first active screening in a village
[19] or matching for the health zone to the expected equilibrium state of an ODE model variant [18].
However, using these values as an approximation for the mixing between villages, we achieve a good match to
both ODE and event-driven stochastic (tau-leap) variants (see supplementary material), while retaining the
efficiency of the Kolmogorov forward equations and the additional benefits of calculating the full probability
distribution. Explicit data on movement, such as a network structure for the amount of travel between
villages, including travel outside the health zone, could refine our predictions, as well as capturing more of
the heterogeneities between villages. However, low frequency of infectious imports to each village, coupled
with minimal differences in the transmission dynamics between villages of the same health zone [19], mean
we would not expect this to greatly influence predictions.
The deterministic ODE method is useful for large populations where we expect average behaviour, and the
event-driven stochastic method is particularly useful for smaller populations, increasing our understanding
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of the stochastic uncertainty and ability to directly measure elimination. However, the Kolmogorov forward
equation approach with connections between villages can be used to capture the dynamics of individual
villages, with bespoke control interventions, with the results translatable between the village level to the
health zone level, providing estimates of elimination of infection at practical spatial scales.
In the future, this modelling approach could be very valuable for assessing not only decisions about
continuation or cessation of screening in specific villages (based on village size and previous detections) but
also provides a method through which the impact of village-level mass drug administration on health zone
transmission dynamics could be assessed. Whilst such as drug is not currently licensed for this type of
delivery, a new compound – acoziborole – which is in phase 3 clinical trials as a single-dose cure, is a possible
candidate [35]. These types of village-scale strategy decisions would be challenging to analyse through health
zone level approaches. In addition, while the tsetse are not explicitly modelled in our approach, our model
is sufficiently flexible that future vector control in these health zones could be incorporated by a reduction
in the force of infection due to a reduction in tsetse populations.
Conclusions
We have shown that a lower-dimensional model of gHAT that operates at the village level can achieve very
similar results to a more biologically realistic version for larger spatial scales, while introducing a method of
obtaining numerically exact results for extinction times and expected number of infected individuals. The
predictions provided are in line with previous deterministic and stochastic results and the model imple-
mentation provides a framework to scale between modelling at a health zone or national level and at the
village level. This is an important development, since the data obtained and the actual interventions (active
screening) conducted are at village level.
The Kolmogorov forward equation model suggests that with mean coverage of active screening and
continuing passive screening, with no additional interventions such as vector control, the infection is almost
certain to persist for long periods. This indicates that additional or intensified controls are required to
achieve elimination of transmission, such as tsetse control, improved passive detection or targeting of high-
risk people in active screening. This model structure expands the range of analytical projections it is possible
to generate and demonstrates the results that can be obtained with a Kolmogorov forward equation model.
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